Esperion Therapeutics
ESPR
#6721
Rank
HK$3.86 B
Marketcap
HK$19.61
Share price
2.02%
Change (1 day)
101.19%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of June 2024 : HK$1.47 Billion

According to Esperion Therapeutics's latest financial reports the company has HK$1.47 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$0.64 B-50.73%
2022-12-31HK$1.30 B-35.53%
2021-12-31HK$2.02 B-14.46%
2020-12-31HK$2.36 B51.19%
2019-12-31HK$1.56 B46.8%
2018-12-31HK$1.06 B-31.9%
2017-12-31HK$1.56 B-4.67%
2016-12-31HK$1.64 B-0.27%
2015-12-31HK$1.64 B100.4%
2014-12-31HK$0.82 B76.27%
2013-12-31HK$0.46 B822.77%
2012-12-31HK$50.47 M313.62%
2011-12-31HK$12.2 M
2002-12-31HK$0.34 B-36.18%
2001-12-31HK$0.54 B0.06%
2000-12-31HK$0.54 B1094.17%
1999-12-31HK$45.86 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$5.94 B 303.49%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$7.23 B 391.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$77.43 B 5,157.15%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$76.22 B 5,075.01%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.94 B 31.93%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.41 B 63.74%๐Ÿ‡บ๐Ÿ‡ธ USA